Embecta Corp. (EMBC) — Stock Score Summary

Embecta Corp. (EMBC) has a MoatMap StockRank of 81/100 based on Quality (67/100), Value (90/100), and Momentum (8/100) factor scores. The current signal is STRONG BUY. Embecta is a spin-off focused on diabetes care (primarily syringes and pen needles). The business is highly leveraged, faces structural headwinds from the rise of GLP-1 drugs reducing insulin injection frequency, and lacks a clear macro tailwind.

Embecta Corp. is a pure-play global medical device company dedicated exclusively to diabetes care, offering a comprehensive portfolio of insulin delivery solutions including pen needles and syringes. Spun off from Becton Dickinson, the company holds a leading market position globally, leveraging extensive distribution networks and established brand trust among patients and healthcare providers. This specialized focus ensures deep expertise and market penetration in a critical healthcare segment.

Key Financial Metrics

Price$3.37
Market Cap$198M
P/E (TTM)1.80
P/E (Forward)1.96
Price/Book-0.32
Return on Invested Capital29.4%
Gross Margin61.9%
Operating Margin19.3%
Revenue Growth-14.4%
Dividend Yield13.5%
Free Cash Flow$196M

Embecta Corp. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Embecta Corp.’s (EMBC) StockRank?
MoatMap’s StockRank for Embecta Corp. (EMBC) is 81/100, with a Strong Buy signal. It is a composite of Quality (67), Value (90), and Momentum (8) factor ranks across MoatMap’s 19,000+ stock universe.
Does Embecta Corp. have an economic moat?
Embecta Corp. (EMBC) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Embecta Corp. a buy, hold, or sell?
MoatMap’s current signal for Embecta Corp. (EMBC) is Strong Buy, based on a StockRank of 81/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Embecta Corp. in?
Embecta Corp. (EMBC) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).
Browse all ranked stocksEMBC deep dive reportAI ChampionsHow we score stocksSense-check another stock